Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Göran Walldius

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|June 2, 2011
The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Hans Garmo, Niklas Hammar, et al.
Cancer|April 28, 2011
Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucoseMieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Annals of Medicine|December 1, 2010
Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney diseaseMartin J Holzmann, Ingmar Jungner, Göran Walldius, et al.
BMC Cancer|November 28, 2018
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?Arunangshu Ghoshal, Hans Garmo, Niklas Hammar, et al.
Journal of Cancer Epidemiology|September 13, 2012
Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS StudyWahyu Wulaningsih, Hans Garmo, Lars Holmberg, et al.
Atherosclerosis|June 13, 2016
Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS studySabine Rohrmann, Hans Garmo, Håkan Malmström, et al.
Clinical Chemistry and Laboratory Medicine|December 4, 2004
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary riskGöran Walldius, Ingmar Jungner, Are H Aastveit, et al.
Scientific Reports|December 25, 2021
The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by ageMozhu Ding, Alexandra Wennberg, Stina Ek, et al.
Diabetes Research and Clinical Practice|April 27, 2013
Country of birth-specific and gender differences in prevalence of diabetes in SwedenAxel C Carlsson, Per E Wändell, Ebba Hedlund, et al.
Annals of Neurology|April 25, 2017
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohortDaniela Mariosa, Niklas Hammar, Håkan Malmström, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|June 2, 2011
The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS studyMieke Van Hemelrijck, Hans Garmo, Niklas Hammar, et al.
Cancer|April 28, 2011
Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucoseMieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al.
Annals of Medicine|December 1, 2010
Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney diseaseMartin J Holzmann, Ingmar Jungner, Göran Walldius, et al.
BMC Cancer|November 28, 2018
Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?Arunangshu Ghoshal, Hans Garmo, Niklas Hammar, et al.
Journal of Cancer Epidemiology|September 13, 2012
Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS StudyWahyu Wulaningsih, Hans Garmo, Lars Holmberg, et al.
Atherosclerosis|June 13, 2016
Association between serum calcium concentration and risk of incident and fatal cardiovascular disease in the prospective AMORIS studySabine Rohrmann, Hans Garmo, Håkan Malmström, et al.
Clinical Chemistry and Laboratory Medicine|December 4, 2004
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary riskGöran Walldius, Ingmar Jungner, Are H Aastveit, et al.
Scientific Reports|December 25, 2021
The association of apolipoproteins with later-life all-cause and cardiovascular mortality: a population-based study stratified by ageMozhu Ding, Alexandra Wennberg, Stina Ek, et al.
Diabetes Research and Clinical Practice|April 27, 2013
Country of birth-specific and gender differences in prevalence of diabetes in SwedenAxel C Carlsson, Per E Wändell, Ebba Hedlund, et al.
Annals of Neurology|April 25, 2017
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohortDaniela Mariosa, Niklas Hammar, Håkan Malmström, et al.
Pageof 8